← Leaderboards
William P Fay
Harry S. Truman Memorial Va Hospital
$8,557,177
Attributed
$12,095,798
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,095,798 · 5
VA$0 · 2
By mechanism
U01$5,584,144 · 1
R01$4,588,714 · 3
P01$1,922,940 · 1
I01$0 · 2
Top collaborators
- Sheila Ann Grant7 shared
- William Monroe Turpin5 shared
Most similar at Harry S. Truman Memorial Va Hospital
Same institution · by research overlap
- Shiyou Chen$16,685,151
- Camila Margarita Manrique Acevedo$5,456,962
- Jaume Padilla$7,120,291
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventAtherosclerosisPlasminogen Activator Inhibitor 1MediatingBlood VesselsPathway InteractionsArteriesBaseNovel StrategiesUniversitiesResearch PersonnelPharmaceutical PreparationsMissouriProteinsCell PhysiologyThrombosisHuman DiseaseMyocardial InfarctionCell MotilityCardiovascular SystemInnovationBurden Of IllnessClinically RelevantFibrinolysis
Grant awards (34)
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence$0
I01 · FY2025 · VA · contact PI
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence$0
I01 · FY2024 · VA · contact PI
Midwest Biomedical Accelerator Consortium: MBArC$123,892
U01 · FY2023 · HL · contact PI
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence$0
I01 · FY2023 · VA · contact PI
Midwest Biomedical Accelerator Consortium: MBArC$980,957
U01 · FY2022 · HL · contact PI
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence$0
I01 · FY2022 · VA · contact PI
Midwest Biomedical Accelerator Consortium: MBArC$980,957
U01 · FY2021 · HL · contact PI
Role of Plasminogen Activator Inhibitor-1 in Adipose Tissue Dysfunction and Atherosclerosis in Metabolic Syndrome$360,227
R01 · FY2021 · HL · contact PI
Midwest Biomedical Accelerator Consortium: MBArC$351,108
U01 · FY2021 · HL · contact PI
Midwest Biomedical Accelerator Consortium: MBArC$1,171,566
U01 · FY2020 · HL · contact PI
Midwest Biomedical Accelerator Consortium: MBArC$980,957
U01 · FY2020 · HL · contact PI
Role of Plasminogen Activator Inhibitor-1 in Adipose Tissue Dysfunction and Atherosclerosis in Metabolic Syndrome$360,212
R01 · FY2020 · HL · contact PI
Midwest Biomedical Accelerator Consortium: MBArC$994,707
U01 · FY2019 · HL · contact PI
Role of Plasminogen Activator Inhibitor-1 in Adipose Tissue Dysfunction and Atherosclerosis in Metabolic Syndrome$362,318
R01 · FY2019 · HL · contact PI
Role of Plasminogen Activator Inhibitor-1 in Adipose Tissue Dysfunction and Atherosclerosis in Metabolic Syndrome$371,803
R01 · FY2018 · HL · contact PI
Role of Fibrinolytic System in Vein Graft Remodeling$0
I01 · FY2016 · VA · contact PI
Role of Fibrinolytic System in Vein Graft Remodeling$0
I01 · FY2015 · VA · contact PI
Role of Fibrinolytic System in Vein Graft Remodeling$0
I01 · FY2014 · VA · contact PI
PAI-1 and Vitronectin in Failure of Coronary Revascularization$351,116
R01 · FY2013 · HL · contact PI
Role of Fibrinolytic System in Vein Graft Remodeling$0
I01 · FY2013 · VA · contact PI
PAI-1 and Vitronectin in Failure of Coronary Revascularization$368,107
R01 · FY2012 · HL · contact PI
Roles of Plasminogen Activator Inhibitor-1 and Vitronectin in Failure of Coronary$371,840
R01 · FY2011 · HL · contact PI
Roles of Plasminogen Activator Inhibitor-1 and Vitronectin in Failure of Coronary$384,746
R01 · FY2010 · HL · contact PI
Regulation of Fibrinolysis at Sites of Arterial Injury$402,951
P01 · FY2007 · HL · contact PI
Regulation of Fibrinolysis at Sites of Arterial Injury$397,445
P01 · FY2006 · HL · contact PI
Regulation of Fibrinolysis at Sites of Arterial Injury$390,350
P01 · FY2005 · HL
Regulation of Fibrinolysis at Sites of Arterial Injury$383,285
P01 · FY2004 · HL
REGULATION OF PLATELET-DEPENDENT THROMBOSIS$328,513
R01 · FY2004 · HL
REGULATION OF PLATELET-DEPENDENT THROMBOSIS$328,721
R01 · FY2003 · HL
REGULATION OF PLATELET-DEPENDENT THROMBOSIS$328,920
R01 · FY2002 · HL
REGULATION OF PLATELET-DEPENDENT THROMBOSIS$331,409
R01 · FY2001 · HL
REGULATION OF FIBRINOLYSIS AT SITES OF ARTERIAL INJURY$135,852
P01 · FY2001 · HL
REGULATION OF PLATELET-DEPENDENT THROMBOSIS$340,782
R01 · FY2000 · HL
REGULATION OF FIBRINOLYSIS AT SITES OF ARTERIAL INJURY$213,057
P01 · FY2000 · HL